Company registration number 11207881 (England and Wales)
Bluestones Medical Complex Care Limited
Financial Statements
For the year ended 31 October 2025
Bluestones Medical Complex Care Limited
Contents
Page
Statement of financial position
1
Notes to the financial statements
2 - 8
Bluestones Medical Complex Care Limited
Statement Of Financial Position
As at 31 October 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
9,000
-
0
Tangible assets
4
70,741
105,858
79,741
105,858
Current assets
Debtors
5
2,190,374
2,132,146
Cash at bank and in hand
56,073
5,828
2,246,447
2,137,974
Creditors: amounts falling due within one year
6
(913,318)
(1,862,234)
Net current assets
1,333,129
275,740
Total assets less current liabilities
1,412,870
381,598
Provisions for liabilities
(19,087)
(27,636)
Net assets
1,393,783
353,962
Capital and reserves
Called up share capital
430
100
Profit and loss reserves
1,393,353
353,862
Total equity
1,393,783
353,962

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 30 July 2026 and are signed on its behalf by:
Mr S  Pendergast
Director
Company registration number 11207881 (England and Wales)
Bluestones Medical Complex Care Limited
Notes to the financial statements
For the year ended 31 October 2025
- 2 -
1
Accounting policies
Company information

Bluestones Medical Complex Care Limited is a private company limited by shares incorporated in England and Wales. The registered office is Chester Business Centre, Union Street, Chester, England, CH1 1QP.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
33.3% straight line
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33.3% Straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Bluestones Medical Complex Care Limited
Notes to the financial statements (continued)
For the year ended 31 October 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Bluestones Medical Complex Care Limited
Notes to the financial statements (continued)
For the year ended 31 October 2025
1
Accounting policies
(Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Bluestones Medical Complex Care Limited
Notes to the financial statements (continued)
For the year ended 31 October 2025
1
Accounting policies
(Continued)
- 5 -
1.10
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14

Significant judgements and estimates

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Although these estimates are based on management's best knowledge of the amount, events or actions, actual results ultimately may differ from those estimates.

 

The estimates are continually evaluated. Revisions to accounting estimates are recognised in the period in which the estimate is revised.

 

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are outlined below.

 

The directors use judgement to provide against bad debts using knowledge of customers and experience. The provisions are revisited after the statement of financial position date to ensure appropriate.

Bluestones Medical Complex Care Limited
Notes to the financial statements (continued)
For the year ended 31 October 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
18
8
3
Intangible fixed assets
Other
£
Cost
At 1 November 2024
-
0
Additions
9,000
At 31 October 2025
9,000
Amortisation and impairment
At 1 November 2024 and 31 October 2025
-
0
Carrying amount
At 31 October 2025
9,000
At 31 October 2024
-
0
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 November 2024
173,288
Additions
25,533
At 31 October 2025
198,821
Depreciation and impairment
At 1 November 2024
67,430
Depreciation charged in the year
60,650
At 31 October 2025
128,080
Carrying amount
At 31 October 2025
70,741
At 31 October 2024
105,858
Bluestones Medical Complex Care Limited
Notes to the financial statements (continued)
For the year ended 31 October 2025
- 7 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
590,775
773,570
Amounts owed by group undertakings
921,652
913,121
Other debtors
677,947
445,455
2,190,374
2,132,146
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
58,747
6,210
Amounts owed to group undertakings
202,601
1,510,581
Taxation and social security
399,098
192,564
Other creditors
252,872
152,879
913,318
1,862,234
7
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Richard Bell
Statutory Auditor:
DJH Audit Limited
Date of audit report:
30 July 2026
8
Operating lease commitments
As lessee
Bluestones Medical Complex Care Limited
Notes to the financial statements (continued)
For the year ended 31 October 2025
8
Operating lease commitments
(Continued)
- 8 -

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
746,394
42,500
9
Parent company

At the year end the immediate and ultimate parent company and controlling party was Bluestones Investment Group Limited, a company registered in England and Wales. The results of the company are included within the consolidated financial statements of Bluestones Investment Group Limited, copies of which can be obtained from Companies House. The company's registered office is Chester Business Centre, Union Street, Chester, CH1 1QP, England.

2025-10-312024-11-01falsefalsefalse30 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityS PendergastP M StratfordD LogueMs J HancockC M F Alfred112078812024-11-012025-10-31112078812025-10-31112078812024-10-3111207881core:IntangibleAssetsOtherThanGoodwill2025-10-3111207881core:IntangibleAssetsOtherThanGoodwill2024-10-3111207881core:OtherPropertyPlantEquipment2025-10-3111207881core:OtherPropertyPlantEquipment2024-10-3111207881core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-3111207881core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3111207881core:ShareCapital2025-10-3111207881core:ShareCapital2024-10-3111207881core:RetainedEarningsAccumulatedLosses2025-10-3111207881core:RetainedEarningsAccumulatedLosses2024-10-3111207881bus:Director12024-11-012025-10-3111207881core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3111207881core:ComputerSoftware2024-11-012025-10-3111207881core:ComputerEquipment2024-11-012025-10-31112078812023-11-012024-10-3111207881core:IntangibleAssetsOtherThanGoodwill2024-10-3111207881core:OtherPropertyPlantEquipment2024-10-3111207881core:OtherPropertyPlantEquipment2024-11-012025-10-3111207881core:CurrentFinancialInstruments2025-10-3111207881core:CurrentFinancialInstruments2024-10-3111207881bus:PrivateLimitedCompanyLtd2024-11-012025-10-3111207881bus:SmallCompaniesRegimeForAccounts2024-11-012025-10-3111207881bus:FRS1022024-11-012025-10-3111207881bus:Audited2024-11-012025-10-3111207881bus:Director22024-11-012025-10-3111207881bus:Director32024-11-012025-10-3111207881bus:Director42024-11-012025-10-3111207881bus:Director52024-11-012025-10-3111207881bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP